| 000 | 01421 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517050703.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc.15.86 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNichols, Mark | |
| 245 | 0 | 0 |
_aNew directions for drug-resistant breast cancer: the CDK4/6 inhibitors. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _cAug 2015 |
||
| 300 |
_a1473-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aBreast _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 6 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xpharmacology |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 7 _gno. 12 _gp. 1473-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc.15.86 _zAvailable from publisher's website |
| 999 |
_c25201389 _d25201389 |
||